Avenue Therapeutics, Inc. (ATXI) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.26
Day's range
$0.33
$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

ATXI Income statement / Annual

Last year (2024), Avenue Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Avenue Therapeutics, Inc.'s net income was -$11.65 M. See Avenue Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $6.65 M $10.36 M $2.70 M $1.25 M $2.87 M $23.19 M $17.70 M $7.80 M $1.38 M $4.00 M
General & Administrative Expenses $4.64 M $4.18 M $5.35 M $2.48 M $2.35 M $3.07 M $4.12 M $3.62 M $997.00 K $918.55 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $4.64 M $4.18 M $5.35 M $2.48 M $2.35 M $3.07 M $4.12 M $3.62 M $997.00 K $842.00 K
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $175.00 K -$99.00 K $0.00 $0.00
Operating Expenses $11.28 M $14.54 M $8.04 M $3.74 M $5.21 M $26.27 M $21.82 M $6.70 M $2.38 M $4.84 M
Cost And Expenses $0.00 $14.54 M $8.04 M $3.74 M $5.21 M $26.27 M $21.82 M $11.42 M $2.38 M $4.84 M
Interest Income -$176.00 K $126.00 K $20.00 K $7.00 K $62.00 K $357.00 K $93.00 K $88.00 K $0.00 $0.00
Interest Expense $0.00 $0.00 $1.16 M $0.00 $0.00 $0.00 $0.00 $375.00 K $612.00 K $417.82 K
Depreciation & Amortization $0.00 $14.54 M $8.04 M $3.74 M $5.21 M $26.27 M $21.82 M $11.42 M $2.38 M $5.28 M
EBITDA -$11.28 M $4.05 M -$8.02 M -$3.73 M -$5.21 M $0.00 $0.00 $0.00 -$188.00 K $440.27 K
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$369.00 K $4.05 M $4.44 M $7.00 K $62.00 K $357.00 K $268.00 K -$837.00 K -$800.00 K -$383.00 K
Income Before Tax -$11.65 M -$10.49 M -$3.60 M -$3.73 M -$5.15 M -$25.91 M -$21.55 M -$12.26 M -$3.18 M -$5.23 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$5.65 M -$7.00 K -$62.00 K -$357.00 K -$268.00 K $287.00 K -$1.77 M -$5.28 M
Net Income -$11.65 M -$10.38 M -$3.55 M -$3.73 M -$5.15 M -$25.91 M -$21.55 M -$12.26 M -$3.18 M -$5.23 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -0.9 -73.6 -1.63 -3.29 -4.65 -24.38 -31.17 -27.71 -5.39 -9.4
EPS Diluted -0.9 -73.48 -1.63 -3.29 -4.65 -24.38 -31.17 -27.71 -5.39 -9.4
Weighted Average Shares Out $12.95 M $141.00 K $29.14 K $1.13 M $1.10 M $1.05 M $682.61 K $442.33 K $589.43 K $556.10 K
Weighted Average Shares Out Diluted $12.95 M $141.22 K $29.14 K $1.13 M $1.10 M $1.05 M $682.61 K $442.33 K $589.43 K $556.10 K
Link